Supplementary Figure S3 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer

Key Points

Combination treatment with PeS-9 and docetaxel enhanced effectiveness against prostate cancer cells.
The treatment resulted in notable changes in 22Rv1 prostate cancer cells, suggesting therapeutic benefits.
The approach focuses on targeted therapy using glucose conjugates and naphthoquinone derivatives.
These findings may lead to improved treatment strategies for advanced prostate cancer management.

This analysis shows the impact of combination treatment with PeS-9 and docetaxel on prostate cancer, indicating a potential new strategy.

Supplementary Figure S3: Effect of combinational treatment with PeS-9 and docetaxel in 22Rv1 prostate cancer cells

No takes yet. Share an insight, caveat, or question.

Busenbender et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Share